Sage Journals: Discover world-class research

Open access

Case report

First published 2023

Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature

Chance H. Bloomer, Elena Gavrila, Kimberly M. Burcher [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023-5

PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples

Katharina Möller, Madeleine Knöll, Elena Bady [...]

Cancer Biomarkers

Open access

Review article

First published 2019

Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer 1

Megan M. Tu, Terry L. Ng, Florus C. De Jong [...]

Bladder Cancer

Open access

Review article

First published 2020

Predicting Responses to Checkpoint Inhibitors in Lymphoma: Are We Up to the Standards of Solid Tumors?

Ah-Reum Jeong, Edward D Ball, Aaron Michael Goodman

Clinical Medicine Insights: Oncology

Open access

Research article

First published 2025

Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis

Linjing Zhou, Yuwei Li, Le Wang [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System

Nunzia Balzano, Annamaria Mascolo, Donatella Ruggiero [...]

Therapeutic Advances in Drug Safety

Retricted access

Review article

First published 2025-8

Adding immune checkpoint inhibitors to chemotherapy in elderly cancer patients: Beneficial for many but not all?

Fausto Petrelli, Antonio Ghidini, Italo Sarno [...]

Tumori Journal

Open access

Research article

First published 2026

Efficacy and safety of induction chemoimmunotherapy in older patients with unresectable stage III NSCLC: a real-world multicenter study

Xingyu Du, Huan Li, Song Guan [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR -mutant lung adenocarcinoma treated with first-line osimertinib

Jia-Jun Wu, Jeng-Sen Tseng, Zhe-Rong Zheng [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025-09

Adverse Events of Immune Checkpoint Inhibitors in Cancer Patients with Comorbid Diabetes: A Real-World Pharmacovigilance Analysis of the FDA Adverse Event Reporting System Database (2011–2025)

Minxia Yang, Di Qiu, Minguang Huang [...]

Cancer Control

Search results